Company News
Company News
Core One Labs Announces Grant of Restricted Share Units
November 09, 2022
Vancouver, British Columbia, Canada – November 9, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
Core One Labs Takes Next Steps to Prepare for Potential Takeover Opportunities
October 21, 2022
Vancouver, British Columbia, Canada – October 21, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
European University to Fund Core One Labs’ Akome Advanced Neurogenesis Stimulation Studies
October 14, 2022
Vancouver, British Columbia, Canada – October 14, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU)...
Read more
Company News
Core One Labs Nearing GMP Production as Canada’s Province of Alberta Announces Game Changing Legislation
October 07, 2022
Vancouver, British Columbia, Canada – October 7, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the...
Read more
Company News
Core One Labs Announces Breakthrough with Proprietary Isolation and Purification Method of Psilocybin from Mushrooms; Prepares Patent Application
September 30, 2022
Vancouver, British Columbia, Canada – September 30, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
Core One Labs Signs Letter of Intent with GMP Manufacturing Partner for Production of Proprietary Psychedelic Compounds
September 23, 2022
Vancouver, British Columbia, Canada – September 23, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more